Takeshi Kanno

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i>¹

Hisataka Yasuda, Nobuyuki Shima, N. Nakagawa et al. · Endocrinology · 1998 · 1.2K citations · Full text

Sclerostin, Immunology, Cell Death +18

Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin

Atsuko Mizuno, Norio Amizuka, Kazuharu Irie et al. · Biochemical and Biophysical Research Communications · 1998 · 771 citations

Severe Osteoporosis, Pathology, Medicine +2

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

Atsuko Mizuno, Takeshi Kanno, M. Hoshi et al. · Journal of Bone and Mineral Metabolism · 2002 · 143 citations

Developmental Biology, Bone Metabolism, Exhibit Severe Osteoporosis +6

A new neuromodulatory pathway with a glial contribution mediated via A_2a adenosine receptors

Tomoyuki Nishizaki, Kanto Nagai, Tamotsu Nomura et al. · Glia · 2002 · 131 citations

Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus

Takeshi Kanno, Tomoyuki Nishizaki, Richard L. Proia et al. · Neuroscience · 2010 · 107 citations

Synaptic Plasticity, Molecular Neuroscience, Molecular Physiology +10